Deciphera Pharmaceuticals Revenue vs. Shares Owned By Institutions
| DCPHDelisted Stock | USD 13.32 0.36 2.63% |
For Deciphera Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Deciphera Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Deciphera Pharmaceuticals LLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Deciphera Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Deciphera Pharmaceuticals LLC over time as well as its relative position and ranking within its peers.
Deciphera |
Deciphera Pharmaceuticals Shares Owned By Institutions vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Deciphera Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Deciphera Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Deciphera Pharmaceuticals LLC is rated below average in revenue category among its peers. It also is rated below average in shares owned by institutions category among its peers . The ratio of Revenue to Shares Owned By Institutions for Deciphera Pharmaceuticals LLC is about 2,267,888 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Deciphera Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Deciphera Revenue vs. Competition
Deciphera Pharmaceuticals LLC is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 10.16 Billion. Deciphera Pharmaceuticals claims roughly 163.36 Million in revenue contributing just under 2% to equities under Health Care industry.
Deciphera Shares Owned By Institutions vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Deciphera Pharmaceuticals |
| = | 163.36 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Deciphera Pharmaceuticals |
| = | 72.03 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Deciphera Shares Owned By Institutions Comparison
Deciphera Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers.
Deciphera Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Deciphera Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Deciphera Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Deciphera Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Deciphera Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Deciphera Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.
Deciphera Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Deciphera Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Deciphera Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Deciphera Pharmaceuticals' important profitability drivers and their relationship over time.
Use Deciphera Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deciphera Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deciphera Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Deciphera Pharmaceuticals Pair Trading
Deciphera Pharmaceuticals LLC Pair Trading Analysis
The ability to find closely correlated positions to Deciphera Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deciphera Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deciphera Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deciphera Pharmaceuticals LLC to buy it.
The correlation of Deciphera Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deciphera Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deciphera Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deciphera Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Deciphera Pharmaceuticals position
In addition to having Deciphera Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Entertainment Thematic Idea Now
Entertainment
Companies from entertainment industry including show business, news and media. The Entertainment theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Deciphera Stock
If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets |